Evidence map›Paper›PMID 39279830›Full record

ArticleArXiv2024

Explainable AI for computational pathology identifies model limitations and tissue biomarkers.

Jakub R Kaczmarzyk, Joel H Saltz, Peter K Koo

Abstract readPreprint
In one paragraph

Article in ArXiv, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jakub R KaczmarzykDepartment of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA.
Joel H SaltzDepartment of Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA.
Peter K KooSimons Center for Quantitative Biology, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008444 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI FROHMAN, MICHAEL A. · 1992 to 2024
$12.6M
NIGMS NIH HHS T32 GM008444
6 · The paper itself

Abstract

Introduction: Deep learning models hold great promise for digital pathology, but their opaque decision-making processes undermine trust and hinder clinical adoption. Explainable AI methods are essential to enhance model transparency and reliability. Methods: We developed HIPPO, an explainable AI framework that systematically modifies tissue regions in whole slide images to generate image counterfactuals, enabling quantitative hypothesis testing, bias detection, and model evaluation beyond traditional performance metrics. HIPPO was applied to a variety of clinically important tasks, including breast metastasis detection in axillary lymph nodes, prognostication in breast cancer and melanoma, and Results: In metastasis detection, HIPPO uncovered critical model limitations that were undetectable by standard performance metrics or attention-based methods. For prognostic prediction, HIPPO outperformed attention by providing more nuanced insights into tissue elements influencing outcomes. In a proof-of-concept study, HIPPO facilitated hypothesis generation for identifying melanoma patients who may benefit from immunotherapy. In Conclusions: HIPPO expands the explainable AI toolkit for computational pathology by enabling deeper insights into model behavior. This framework supports the trustworthy development, deployment, and regulation of weakly-supervised models in clinical and research settings, promoting their broader adoption in digital pathology.

Identifiers

PMID39279830
PMCPMC11398542

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.